Manson Abigail L, Abeel Thomas, Galagan James E, Sundaramurthi Jagadish Chandrabose, Salazar Alex, Gehrmann Thies, Shanmugam Siva Kumar, Palaniyandi Kannan, Narayanan Sujatha, Swaminathan Soumya, Earl Ashlee M
Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Delft Bioinformatics Lab, Delft University of Technology, The Netherlands.
Clin Infect Dis. 2017 Jun 1;64(11):1494-1501. doi: 10.1093/cid/cix169.
BACKGROUND.: India is home to 25% of all tuberculosis cases and the second highest number of multidrug resistant cases worldwide. However, little is known about the genetic diversity and resistance determinants of Indian Mycobacterium tuberculosis, particularly for the primary lineages found in India, lineages 1 and 3.
METHODS.: We whole genome sequenced 223 randomly selected M. tuberculosis strains from 196 patients within the Tiruvallur and Madurai districts of Tamil Nadu in Southern India. Using comparative genomics, we examined genetic diversity, transmission patterns, and evolution of resistance.
RESULTS.: Genomic analyses revealed (11) prevalence of strains from lineages 1 and 3, (11) recent transmission of strains among patients from the same treatment centers, (11) emergence of drug resistance within patients over time, (11) resistance gained in an order typical of strains from different lineages and geographies, (11) underperformance of known resistance-conferring mutations to explain phenotypic resistance in Indian strains relative to studies focused on other geographies, and (11) the possibility that resistance arose through mutations not previously implicated in resistance, or through infections with multiple strains that confound genotype-based prediction of resistance.
CONCLUSIONS.: In addition to substantially expanding the genomic perspectives of lineages 1 and 3, sequencing and analysis of M. tuberculosis whole genomes from Southern India highlight challenges of infection control and rapid diagnosis of resistant tuberculosis using current technologies. Further studies are needed to fully explore the complement of diversity and resistance determinants within endemic M. tuberculosis populations.
印度的结核病病例数占全球总数的25%,耐多药病例数位居世界第二。然而,对于印度结核分枝杆菌的遗传多样性和耐药决定因素,尤其是在印度发现的主要谱系1和谱系3,人们了解甚少。
我们对从印度南部泰米尔纳德邦蒂鲁瓦勒尔和马杜赖地区196名患者中随机选取的223株结核分枝杆菌菌株进行了全基因组测序。通过比较基因组学,我们研究了遗传多样性、传播模式和耐药性的演变。
基因组分析显示,(1)谱系1和谱系3菌株的流行情况,(2)同一治疗中心患者之间菌株的近期传播情况,(3)患者随时间出现的耐药性,(4)耐药性的获得顺序符合来自不同谱系和地区的菌株的典型情况,(5)与针对其他地区的研究相比,已知的耐药性赋予突变在解释印度菌株的表型耐药性方面表现不佳,(6)耐药性可能是通过先前未涉及耐药性的突变产生的,或者是通过感染多种菌株导致基于基因型的耐药性预测混淆。
除了大幅扩展谱系1和谱系3的基因组视角外,对印度南部结核分枝杆菌全基因组的测序和分析凸显了使用当前技术进行感染控制和耐药结核病快速诊断的挑战。需要进一步研究以充分探索地方结核分枝杆菌群体中的多样性和耐药决定因素的补充情况。